中轴型脊柱关节炎快速脊柱放射学进展的相关因素:基于深度学习mSASSS评分的医院回顾性队列研究
该研究纳入242例中轴型脊柱关节炎患者,使用深度学习模型评估mSASSS,分析379个观察间期。结果显示约27%间期出现快速放射学进展(ΔmSASSS/年>1),基线年龄较大(尤其≥40岁)为独立相关因素,而较高累积NSAIDs剂量与快速进展负相关。
要点
- 约27%的观察间期出现快速脊柱放射学进展(ΔmSASSS/年>1)。
- 基线年龄较大(尤其≥40岁)与快速mSASSS进展独立相关(aOR 1.03)。
- 观察间期内较高累积NSAIDs剂量与快速进展负相关(aOR 0.38)。
核心结论
- 基线年龄较大是快速脊柱放射学进展的相关因素,而足量NSAIDs使用是保护因素。
研究设计与样本
- 医院回顾性队列研究,纳入242例axSpA患者,2002至2024年间至少两次侧位脊柱X线,共379个观察间期。
- 采用深度学习模型进行mSASSS评分,应用时间依赖广义估计方程(GEE)分析快速进展(ΔmSASSS/年>1)的相关因素。
主要发现
- 记录间期的平均mSASSS进展为0.5/年,26.7%的间期进展>1/年;入组患者的平均进展为0.6/年,27.3%的间期进展>1/年。
- 基线mSASSS时的年龄(尤其≥40岁)与快速mSASSS进展独立相关(aOR 1.03;95%CI 1.003-1.06)。
- 观察间期内较高累积NSAIDs剂量与快速mSASSS进展负相关(aOR 0.38;95%CI 0.19-0.75)。
- 观察间期内累积TNF抑制剂和司库奇尤单抗剂量与快速mSASSS进展无关。
关键数值与推荐
- 快速脊柱放射学进展定义为ΔmSASSS/年>1。
- 基线年龄与快速进展的aOR为1.03(95%CI 1.003-1.06)。
- 累积NSAIDs剂量与快速进展的aOR为0.38(95%CI 0.19-0.75)。
临床怎么用
- 对于基线年龄较大(尤其≥40岁)的axSpA患者,应关注快速脊柱放射学进展风险。
- 足量NSAIDs使用可能与降低快速放射学进展风险相关,但需结合患者具体情况。
- TNF抑制剂和司库奇尤单抗的累积剂量在本研究中未显示与快速进展独立相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify associated and protective factors of rapid spinal radiographic progression in axial spondyloarthritis (axSpA) using artificial intelligence (AI). METHODS: We conducted a hospital-based retrospective cohort study involving 242 axSpA patients taken ≥2 lateral spine radiographs between 2002 and 2024. Spinal damage was assessed with modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) by a deep learning model. Each pair of consecutive radiographs defined an observational interval (total 379 intervals); annual mSASSS progression rate was calculated for each interval. Demographics, clinical features, baseline mSASSS, activity indices, cumulative dosage of prescriptions, and laboratory recordings were collected. Time-dependent generalized estimating equations (GEE) were applied to identify associated or protective factors of rapid spinal radiographic progression (ΔmSASSS/year >1), accounting for within-patient correlation. RESULTS: For recorded intervals, mean mSASSS progression was 0.5/year; 26.7% of intervals showed progression >1/year. For enrolled patients, mean mSASSS progression was 0.6/year; 27.3% of intervals showed progression >1/year. Conditional multivariable GEE analysis revealed age at baseline mSASSS, especially ≥40 years, was independently associated with rapid mSASSS progression [adjusted odds ratio (aOR), 1.03; 95% confidence interval (CI), 1.003-1.06]. Higher cumulative dosage of non-steroidal anti-inflammatory drugs (NSAIDs) during the intervals was negatively associated with rapid mSASSS progression (aOR, 0.38; 95% CI, 0.19-0.75). Cumulative dosage of tumor necrosis factor inhibitors and secukinumab during the intervals was independent of rapid mSASSS progression. CONCLUSIONS: Using AI-assisted mSASSS scoring, this retrospective cohort study identified older age at assessment as an associated factor and full-dose NSAIDs use as protective factor for rapid spinal radiographic progression.
引用
- Kao CM, Chen YH, Huang WN, et al. Factors associated with rapid spinal radiographic progression in patients with axial spondyloarthritis: A hospital-based retrospective cohort study with mSASSS scoring using deep learning model. Semin Arthritis Rheum. 2025. PMID: 41418417. doi:10.1016/j.semarthrit.2025.152888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。